Topics
Glioblastoma | Treatment | Surgery | Resection extent
Home > Publications > Topics > Glioblastoma > Treatment > Surgery > Resection extent
Doron O, Wong T, Ablyazova F, Singha S, Cavallaro J, Ben-Shalom N,
D'Amico RS, Harshan M, McKeown A, Zlochower A, Langer DJ, Boockvar
JA.
Results from a first-in-human phase
i safety trial to evaluate the use of a vascularized
pericranial/temporoparietal fascial flap to line the resection
cavity following resection of newly diagnosed glioblastoma.
J
Neurooncol. 2024 Apr 26. doi:
10.1007/s11060-024-04647-w. PMID:
38664311. Interventional study. ˍ
Gerritsen JKW, Young JS, Chang SM, Krieg SM, Jungk C, van den Bent
MJ, Satoer DD, Ille S, Schucht P, Nahed BV, Broekman MLD, Berger
M, De Vleeschouwer S, Vincent AJPE.
SUPRAMAX-study:
supramaximal resection versus maximal resection for glioblastoma
patients: study protocol for an international multicentre
prospective cohort study (ENCRAM 2201).
BMJ
Open. 2024 Apr 29;14(4):e082274. doi:
10.1136/bmjopen-2023-082274. PMID:
38684246. Interventional study protocol. ˍ
Sonoda Y, Sekino Y, Mizusawa J, Shibahara I, Sasaki K, Sekita T,
Ichikawa M, Igaki H, Kinoshita M, Shibahara J, Ichimura K, Arakawa
Y, Fukuda H, Narita Y.
AB012. A phase
III randomized trial of gross total resection versus possible
resection of fluid-attenuated inversion recovery (FLAIR)
hyperintensity lesion on magnetic resonance image for newly
diagnosed supratentorial glioblastoma (JCOG2209).
Chin
Clin Oncol. 2024 Aug 30;13(Suppl 1):AB012. doi:
10.21037/cco-24-ab012. PMID:
39295330. Interventional study. ˍ
Teske NC, Jung LB, Teske N, Thon N, Tonn JC, Karschnia P.
The
inconsistent terminology for the extent of resection in
glioblastoma: A systematic review on 6 decades of
neuro-oncological studies.
Neuro
Oncol. 2024 Dec 26:noae254. doi:
10.1093/neuonc/noae254. PMID:
39723569. Review˰ ˍ
Schneider M, Potthoff AL, Ahmadipour Y, Borger V, Clusmann H,
Combs SE, Czabanka M, Dührsen L, Etminan N, Freiman TM,
Gerlach R, Gessler F, Giordano FA, Gkika E, Goldbrunner R, Güresir
E, Hamou H, Hau P, Ille S, Jägersberg M, Keric N,
Khaleghi-Ghadiri M, König R, Konczalla J, Krenzlin H, Krieg
S, McLean AL, Layer JP, Lehmberg J, Malinova V, Meyer B, Meyer HS,
Miller D, Müller O, Musahl C, Pregler BEF, Rashidi A, Ringel
F, Roder C, Rössler K, Rohde V, Sandalcioglu IE, Schäfer
N, Schaub C, Schmidt NO, Schubert GA, Seidel C, Seliger C, Senft
C, Shawarba J, Steinbach J, Stöcklein V, Stummer W, Sure U,
Tabatabai G, Tatagiba M, Thon N, Timmer M, Wach J, Wagner A, Wirtz
CR, Zeiler K, Zeyen T, Schuss P, Surges R, Fuhrmann C, Paech D,
Schmid M, Borck Y, Pietsch T, Struck R, Radbruch A, Helmstaedter
C, Németh R, Herrlinger U, Vatter H.
The
ATLAS/NOA-29 study protocol: a phase III randomized controlled
trial of anterior temporal lobectomy versus gross-total resection
in newly-diagnosed temporal lobe glioblastoma.
BMC
Cancer. 2025 Feb 20;25(1):306. doi:
10.1186/s12885-025-13682-3. PMID:
39979825. Interventional study protocol.
ˍ
Wach J, Vychopen M, Güresir E.
Prognostic
revalidation of RANO categories for extent of resection in
glioblastoma: a reconstruction of individual patient data.
J
Neurooncol. 2025 Feb 24. doi:
10.1007/s11060-025-04950-0. PMID:
39992571. Review. ˍ
Molecular-based decision-making
Drexler R, Lim M, Hervey-Jumper SL.
Molecular-based
decision-making in glioblastoma surgery: when to aim for
supramaximal resection.
Neuro
Oncol. 2025 Mar 3:noaf062. doi:
10.1093/neuonc/noaf062. PMID:
40037513. Review˰ ˍ